Has Paula Guinnip, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,582 in general payments to Paula Guinnip, MD across 60 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paula Guinnip, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paula Guinnip, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paula Guinnip, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Tahlequah, OKNPI 1023239720

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (53.0%), food and beverage and education — rather than concentrated in one kind of arrangement. Bard Peripheral Vascular, Inc. accounts for 69.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $2,667 and has fallen 91.3% since, to $232 in 2025.

$3,582in general payments, 2019–2025

Across 60 payments — averaging $59.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bard Peripheral Vascular, Inc.$2K
Boston Scientific$404
Angiodynamics, Inc.$395
Abiomed$195
Medicomp Inc$34
E.r. Squibb & Sons, L.L.C.$32
plus $48 from 2 others

What the payments were for

Travel & lodging$1,89953%
Food & beverage$1,37038%
Education$3139%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bard Peripheral Vascular, Inc.	20	$2,473
Boston Scientific	29	$404
Angiodynamics, Inc.	3	$395
Abiomed	2	$195
Medicomp Inc	2	$34
E.r. Squibb & Sons, L.L.C.	2	$32
Lemaitre Vascular, Inc.	1	$29
Heartflow, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Venclose Maven Catheter$1,537
VenaCure 1470 Pro$313

How this compares

$3,582 in reported general payments places this provider in the 55th percentile of 48 thoracic surgery (cardiothoracic vascular surgery) providers in Oklahoma.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$1,476,976

Medicare patients

109

Services billed

1,649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	18	$16,747
OzempicSemaglutide	12	$12,663
EntrestoSacubitril/Valsartan	16	$12,444
XareltoRivaroxaban	15	$10,532
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	13	$3,178
ClopidogrelClopidogrel Bisulfate	31	$348
Amitriptyline Hcl	16	$279
Clonidine Hcl	40	$229
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	17	$82

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Tahlequah

Matthew CooperTulsa$1.1M
James LongOklahoma City$634K
Kelly NagasawaTulsa$46K
Charles ElkinsOklahoma City$42K
James ReinersmanOklahoma City$40K
Ajit TharakanTulsa$30K
Michael PhillipsTulsa$30K
David VanhooserOklahoma City$25K
Paul KempeTulsa$18K
Michael CannonOklahoma City$18K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →